Landmark Clinical Trial Application

If you are an investigator and wish to be nominated to participate in PlaqueTec's landmark clinical trial, you may fill out the application form below.

The PlaqueTec LBS™ is currently approved for use in the European Economic Area (EEA) only. PlaqueTec is in the process of  filing with regulatory authorities in other markets.

PlaqueTec © 2018